Kyowa Hakko Bio Co., Ltd.FDA
- FEI
- 3007807424
- Record date
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- Japan
Every published Form FDA 483 issued in April 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
7
Published 483s in April 2022
7
Distinct firms
| Company | FEI | Establishment type | Location | FDA date | Source |
|---|---|---|---|---|---|
| Kyowa Hakko Bio Co., Ltd. | 3007807424 | Active Pharmaceutical Ingredient Manufacturer | Japan | FDA | |
| Lynn Oaks Compounding Pharmacy | 3021028639 | Producer of Non Sterile Drug Products | California, United States | FDA | |
| Providence Health and Services Washington Dba Providence Infusion Hospital Services | 3014577316 | Outsourcing Facility | Washington, United States | FDA | |
| New England Life Care, Inc. dba Advanced Compounding Solutions | 3010371376 | Outsourcing Facility | Massachusetts, United States | FDA | |
| US Specialty Formulations LLC | 3010680515 | Outsourcing Facility | Pennsylvania, United States | FDA | |
| Brookfield Medical/Surgical Supply, Inc. | 3011430551 | Outsourcing Facility | Connecticut, United States | FDA | |
| Nephron Sterile Compounding Center LLC | 3011158388 | Outsourcing Facility | South Carolina, United States | FDA |